Ralph Müeller

2.2k total citations
44 papers, 973 citations indexed

About

Ralph Müeller is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Ralph Müeller has authored 44 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 20 papers in Surgery and 20 papers in Epidemiology. Recurrent topics in Ralph Müeller's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (14 papers). Ralph Müeller is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (20 papers) and Eosinophilic Esophagitis (14 papers). Ralph Müeller collaborates with scholars based in Germany, Austria and Hungary. Ralph Müeller's co-authors include Roland Greinwald, Wolfgang Kruis, Juris Pokrotnieks, Stephan Miehlke, I Rácz, M. Horyński, M Bátovský, Gediminas Kiudelis, Ahmed Madisch and Simon Bar–Meir and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Cardiology.

In The Last Decade

Ralph Müeller

43 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralph Müeller Germany	15	623	575	422	115	112	44	973
Valle García-Sánchez Spain	15	538 0.9×	511 0.9×	201 0.5×	42 0.4×	39 0.3×	42	818
Michele Rubin United States	17	585 0.9×	432 0.8×	596 1.4×	40 0.3×	86 0.8×	28	919
Isolde Aerden Belgium	12	1.5k 2.4×	1.1k 2.0×	821 1.9×	79 0.7×	57 0.5×	21	1.8k
Marla Dubinsky United States	9	1.5k 2.4×	1.1k 1.8×	585 1.4×	149 1.3×	69 0.6×	19	1.8k
Kelvin T. Thia Singapore	10	1.3k 2.1×	965 1.7×	688 1.6×	63 0.5×	28 0.3×	16	1.5k
G Järnerot Sweden	8	913 1.5×	637 1.1×	473 1.1×	56 0.5×	39 0.3×	12	1.1k
Marlene L. Bambrick United States	12	886 1.4×	688 1.2×	619 1.5×	25 0.2×	74 0.7×	18	1.2k
Jeanne Emmons United States	11	431 0.7×	593 1.0×	331 0.8×	103 0.9×	63 0.6×	18	884
Philippe de Saussure Switzerland	14	233 0.4×	282 0.5×	201 0.5×	76 0.7×	39 0.3×	22	584
Sieglinde Angelberger Austria	13	401 0.6×	382 0.7×	291 0.7×	198 1.7×	21 0.2×	32	839

Countries citing papers authored by Ralph Müeller

Since Specialization

Citations

This map shows the geographic impact of Ralph Müeller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Müeller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Müeller more than expected).

Fields of papers citing papers by Ralph Müeller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Müeller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Müeller. The network helps show where Ralph Müeller may publish in the future.

Co-authorship network of co-authors of Ralph Müeller

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Müeller. A scholar is included among the top collaborators of Ralph Müeller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Müeller. Ralph Müeller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lucendo, Alfredo J., Stephan Miehlke, Arjan Bredenoord, et al.. (2024). Sa1283 MAINTENANCE TREATMENT WITH ORODISPERSIBLE BUDESONIDE IS NOT ASSOCIATED WITH CHANGES IN BONE BIOMARKERS IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE): RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 48-WEEK TRIAL (STUDY BUL-2/EER).. Gastroenterology. 166(5). S–416.

Kruis, Wolfgang, et al.. (2023). Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis. United European Gastroenterology Journal. 11(8). 775–783. 13 indexed citations

Dignaß, Axel, Wolfgang Stremmel, M. Horyński, et al.. (2023). Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials. Clinical Gastroenterology and Hepatology. 22(4). 810–820.e7. 2 indexed citations

Müeller, Ralph, Alain Schoepfer, Alex Straumann, et al.. (2023). Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment. Clinical Gastroenterology and Hepatology. 22(7). 1528–1530.e3. 4 indexed citations

Fiehn, Anne‐Marie Kanstrup, Stephan Miehlke, Daniela E. Aust, et al.. (2020). Distribution of histopathological features along the colon in microscopic colitis. International Journal of Colorectal Disease. 36(1). 151–159. 19 indexed citations

Schlag, Christoph, Stephan Miehlke, Alfredo J. Lucendo, et al.. (2019). Mo1129 – Efficacy of Budesonide Orodispersible Tablets for Induction of Remission in Patients with Active Eosinophilic Esophagitis: Results from the 6-Weeks Open-Label Treatment Phase of Eos-2 Trial. Gastroenterology. 156(6). S–715. 4 indexed citations

Straumann, Alex, Stephan Miehlke, Michael Vieth, et al.. (2018). Sa1145 - Predictors for Early Versus Delayed Response to Budesonide Orodispersible Tablets in Eosinophilic Esophagitis Treatment: A Subgroup Analysis from the Pivotal Trial Eos-1. Gastroenterology. 154(6). S–256. 2 indexed citations

Schölmerich, Jürgen, Klaus Fellermann, Frank Seibold, et al.. (2016). A Randomised, Double-blind, Placebo-controlled Trial ofTrichuris suisova in Active Crohn’s disease. Journal of Crohn s and Colitis. 11(4). jjw184–jjw184. 54 indexed citations

Münch, Andreas, Curt Tysk, Johan Bohr, et al.. (2015). Smoking Status Influences Clinical Outcome in Collagenous Colitis. Journal of Crohn s and Colitis. 10(4). 449–454. 23 indexed citations

10.

Dignaß, Axel, I Altorjay, Ivan Bunganič, et al.. (2014). Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 8(9). 970–980. 29 indexed citations

11.

Wolff, Sebastián, Grischa Terheggen, Ralph Müeller, et al.. (2013). Are Endoscopic Endpoints Reliable in Therapeutic Trials of Ulcerative Colitis?. Inflammatory Bowel Diseases. 19(12). 2611–2615. 10 indexed citations

12.

Angelberger, Sieglinde, Elke Schaeffeler, Alexander Teml, et al.. (2013). Mucosal Improvement in Patients With Moderate to Severe Postoperative Endoscopic Recurrence of Crohn’s Disease and Azathioprine Metabolite Levels. Inflammatory Bowel Diseases. 19(3). 590–598. 14 indexed citations

13.

Leifeld, Ludger, J Morgenstern, Peter G. Gibson, et al.. (2011). Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis. Alimentary Pharmacology & Therapeutics. 34(9). 1115–1122. 25 indexed citations

14.

Kruis, Wolfgang, Laimas Virginijus Jonaitis, Juris Pokrotnieks, et al.. (2010). Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis. Alimentary Pharmacology & Therapeutics. 33(3). 313–322. 63 indexed citations

15.

Groß, Volker, Ivan Bunganič, E. А. Belousova, et al.. (2010). 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial. Journal of Crohn s and Colitis. 5(2). 129–138. 51 indexed citations

16.

Reinisch, Walter, Sieglinde Angelberger, Wolfgang Petritsch, et al.. (2010). Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut. 59(6). 752–759. 127 indexed citations

17.

Miehlke, Stephan, Ahmed Madisch, Eberhard Kuhlisch, et al.. (2009). Budesonide Is Effective in Treating Lymphocytic Colitis: A Randomized Double-Blind Placebo-Controlled Study. Gastroenterology. 136(7). 2092–2100. 94 indexed citations

18.

Kruis, Wolfgang, Gediminas Kiudelis, I Rácz, et al.. (2008). Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial. Gut. 58(2). 233–240. 145 indexed citations

19.

Eliakim, Rami, Limas Kupčinskas, Kęstutis Adamonis, et al.. (2007). Clinical trial: randomized‐controlled clinical study comparing the efficacy and safety of a low‐volume vs. a high‐volume mesalazine foam in active distal ulcerative colitis. Alimentary Pharmacology & Therapeutics. 26(9). 1237–1249. 30 indexed citations

20.

Costa, Ricardo A., Alexandra J. Lansky, Alexandre Abizaid, et al.. (2006). Angiographic Results of the First Human Experience With the Biolimus A9 Drug-Eluting Stent for De Novo Coronary Lesions. The American Journal of Cardiology. 98(4). 443–446. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact